Verus Capital Partners’s CapForce IBD 50 ETF FFTY Stock Holding History

Verus Capital Partners’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-500	Closed	-$17K	–	1510
2019 Q4	$17K	Buy	+500	New	+$16.9K	0.01%	950

Other funds holding FFTY

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FAAS

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Verus Capital Partners's FFTY Position: Q1 2020 in Review

Verus Capital Partners sold out of CapForce IBD 50 ETF (FFTY) in Q1 2020, closing a stake of 500 shares — an estimated $17K sold.

Verus Capital Partners first reported a position in FFTY in Q4 2019 and held it in 1 quarter. The position peaked at $17K in Q4 2019. 67 funds tracked by Wall St. Rank hold FFTY as of Q1 2020.

Verus Capital Partners reported no remaining CapForce IBD 50 ETF position as of Q1 2020 after selling out during the quarter.
Verus Capital Partners sold 500 CapForce IBD 50 ETF shares in Q1 2020, an estimated $17K.
Verus Capital Partners first reported a position in CapForce IBD 50 ETF in Q4 2019 and held it in 1 quarter.
Verus Capital Partners's CapForce IBD 50 ETF position peaked at $17K in Q4 2019.
67 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.